Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
Jeffrey A. Klomp, Jennifer E. Klomp, Clint A. Stalnecker, et al.
Science (2024) Vol. 384, Iss. 6700
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
Jennifer E. Klomp, J. Nathaniel Diehl, Jeffrey A. Klomp, et al.
Science (2024) Vol. 384, Iss. 6700
Open Access | Times Cited: 20
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
Caitlin A. McIntyre, Adrien Grimont, Jiwoon Park, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1614-1629.e5
Closed Access | Times Cited: 13
A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer
Anupriya Singhal, Hannah C. Styers, Jonathan Rub, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2122-2134
Closed Access | Times Cited: 9
KRAS Oncoprotein Signaling in Cancer
Piro Lito
New England Journal of Medicine (2025) Vol. 392, Iss. 3, pp. 296-298
Closed Access
Targeting MXD1 sensitises pancreatic cancer to trametinib
Shaoping Zhang, Shuang Deng, Ji Liu, et al.
Gut (2025), pp. gutjnl-333408
Closed Access
Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells
Chuan Wang, Ya-Chin Hou, Yi‐Kai Hong, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Advancements in proteogenomics for preclinical targeted cancer therapy research
Yuying Suo, Yuanli Song, Yuqiu Wang, et al.
Biophysics Reports (2025) Vol. 11, Iss. 1, pp. 56-56
Open Access
Artificial intelligence in tumor drug resistance: Mechanisms and treatment prospects
Jianyou Gu, Junfeng Zhang, Silüe Zeng, et al.
(2025)
Closed Access
Drugging mutant KRAS by disrupting binding to effectors and GTP
Adrienne D. Cox, Channing J. Der
Nature Cancer (2025)
Closed Access
STAT3 Sustains Tumorigenicity Following Mutant KRAS Ablation
Stephen D’Amico, Varvara Kirillov, Jingxuan Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress
Jay Ramanlal Anand, Gaith N. Droby, Sayali Joseph, et al.
NAR Cancer (2025) Vol. 7, Iss. 1
Open Access
Copper-KRAS-COX2 Axis: A Therapeutic Vulnerability in Pancreatic Cancer
Joyeeta Roy, Rima Mouawad, Armita Kyani, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Enhancing KRAS G12D inhibitor sensitivity in pancreatic cancer through SHP2/PI3K pathway
Miao Hao, Tian‐Xing Zhang, Dan Dong, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Intestinal microbiota-derived d-(+)-malic acid promotes pBD1 expression via p-p38/ATF1 signaling pathway to maintain porcine intestinal health
Tao Gong, Xiaoxi Lu, Hong Zhang, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114552-114552
Closed Access
RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms
Xiaojuan Yang, Hong Wu
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
Junshu Li, Wencheng Zhou, Huiling Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 4
Unveiling the Promise: Navigating Clinical Trials 1978–2024 for PDAC
A. Domínguez, M Perz, Yi Xu, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3564-3564
Open Access | Times Cited: 1
From precursor to cancer: decoding the intrinsic and extrinsic pathways of pancreatic intraepithelial neoplasia progression
Sarah E. Graham, Mariia Dmitrieva, Débora B. Vendramini‐Costa, et al.
Carcinogenesis (2024) Vol. 45, Iss. 11, pp. 801-816
Closed Access | Times Cited: 1
Kinase Plasticity in Response to Vandetanib Enhances Sensitivity to Tamoxifen and Identifies Co-Treatment Strategies in Estrogen Receptor Positive Breast Cancer
Rasha T. Kakati, Austin A. Whitman, Santiago Haase, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Negative regulation of APC/C activation by MAPK-mediated attenuation of Cdc20Slp1under stress
Li Sun, Xuejin Chen, Chunlin Song, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Negative regulation of APC/C activation by MAPK-mediated attenuation of Cdc20Slp1 under stress
Li Sun, Xuejin Chen, Chunlin Song, et al.
eLife (2024) Vol. 13
Open Access
Reporter-based screening identifies RAS-RAF stabilizing mutations as drivers of resistance to broad-spectrum RAS inhibition in colorectal cancer
Oleksandra Aust, Eric Blanc, Mareen Lüthen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
The KRAS mutational spectrum and its clinical implications in pancreatic cancer
Luigi Perelli, Giannicola Genovese, Giulio Draetta
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1494-1496
Closed Access
Negative regulation of APC/C activation by MAPK-mediated attenuation of Cdc20Slp1 under stress
Li Sun, Xuejin Chen, Chunlin Song, et al.
(2024)
Open Access
Negative regulation of APC/C activation by MAPK-mediated attenuation of Cdc20Slp1 under stress
Li Sun, Xuejin Chen, Chunlin Song, et al.
eLife (2024) Vol. 13
Open Access
Page 1 - Next Page

Scroll to top